Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Celularity (CELU) EPS (Weighted Average and Diluted) (2020 - 2025)

Celularity has reported EPS (Weighted Average and Diluted) over the past 6 years, most recently at -$0.88 for Q3 2025.

  • Quarterly results put EPS (Weighted Average and Diluted) at -$0.88 for Q3 2025, down 20.55% from a year ago — trailing twelve months through Sep 2025 was -$3.33 (down 172.95% YoY), and the annual figure for FY2024 was -$2.64, up 76.04%.
  • EPS (Weighted Average and Diluted) for Q3 2025 was -$0.88 at Celularity, up from -$1.02 in the prior quarter.
  • Over the last five years, EPS (Weighted Average and Diluted) for CELU hit a ceiling of $1.02 in Q4 2022 and a floor of -$4.98 in Q3 2023.
  • Median EPS (Weighted Average and Diluted) over the past 5 years was -$0.66 (2024), compared with a mean of -$0.96.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): skyrocketed 115.87% in 2021 and later tumbled 16700.0% in 2023.
  • Celularity's EPS (Weighted Average and Diluted) stood at $0.51 in 2021, then skyrocketed by 100.0% to $1.02 in 2022, then decreased by 17.65% to $0.84 in 2023, then crashed by 170.24% to -$0.59 in 2024, then plummeted by 49.15% to -$0.88 in 2025.
  • The last three reported values for EPS (Weighted Average and Diluted) were -$0.88 (Q3 2025), -$1.02 (Q2 2025), and -$0.84 (Q1 2025) per Business Quant data.